CompBioMed
Centre of Excellence
CompBioMed
European Union
CompBioMed is collectively redirecting substantial research effort and funding to swiftly focus on computational investigations that will improve the understanding of SARS-CoV-2 virus and the associated COVID-19 disease, and accelerate the development of treatment options, including antiviral drugs and vaccines.
CompBioMed’s work includes bioinformatics analysis and simulation, molecular modelling, electronic structure calculations, epitope analysis, machine learning, epidemiological studies, and the creation and hosting of a growing collection of relevant datasets. Six different areas of research are being undertaken:
- computational drug screening;
- epitope analysis;
- drug toxicity;
- computational epidemiology;
- virus evolutionary analysis;
- host response analysis.
